نتائج البحث

Cabergoline Induced Pathological Gambling in an Adolescent with Prolactinoma

• Authors : Tercan U; İstanbul University, İstanbul Faculty of Medicine, Department of Pediatric Endocrinology, İstanbul, Türkiye; Sarban E

Subjects: Cabergoline*/Cabergoline*/Cabergoline*/adverse effects ; Prolactinoma*/Prolactinoma*/Prolactinoma*/drug therapy ; Pituitary Neoplasms*/Pituitary Neoplasms*/Pituitary Neoplasms*/drug therapy

• Source: Journal of clinical research in pediatric endocrinology [J Clin Res Pediatr Endocrinol] 2026 May 22; Vol. 18 (Suppl 1), pp. 64-69. Date of Electronic Publication: 2025 Jan 24.Publisher: Galenos Yayınevi Country of Publication: Turkey NLM ID: 101519456 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Management outcomes of prolactinoma: a retrospective study from Southern Iraq.

• Authors : Alobaidy HF; Al-Hassan Metabolism, Endocrine, and Diabetes Center, Karbala, Iraq.; Alidrisi HA

Subjects: Prolactinoma*/Prolactinoma*/Prolactinoma*/therapy ; Prolactinoma*/Prolactinoma*/Prolactinoma*/drug therapy ; Prolactinoma*/Prolactinoma*/Prolactinoma*/pathology

• Source: Journal of medicine and life [J Med Life] 2025 Sep; Vol. 18 (9), pp. 869-877.Publisher:

تفاصيل العنوان

Cholesterol-activated stress granules reduce the membrane localization of DRD2 and promote prolactinoma dopamine agonists resistance.

• Authors : Peng Y; Multidisciplinary Center for Pituitary Adenomas of Chongqing, Department of Neurosurgery, Xinqiao Hospital, Army Medical University, 183 Xinqiao Main Street, Shapingba District, Chongqing, China.; Yin H

Subjects: Prolactinoma*/Prolactinoma*/Prolactinoma*/metabolism ; Prolactinoma*/Prolactinoma*/Prolactinoma*/drug therapy ; Prolactinoma*/Prolactinoma*/Prolactinoma*/pathology

• Source: Acta neuropathologica communications [Acta Neuropathol Commun] 2025 Apr 25; Vol. 13 (1), pp. 84. Date of Electronic Publication: 2025 Apr 25.Publisher: BioMed Central Country of Publication: England NLM ID: 101610673 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-5960

تفاصيل العنوان

Elucidating Clinical Queries for Tailored Therapy in Patients with Prolactinoma.

• Authors : Lee MH; University of Medicine and Health Sciences, New York, NY, USA.; Hong JW

Subjects: Prolactinoma*/Prolactinoma*/Prolactinoma*/drug therapy ; Pituitary Neoplasms*/Pituitary Neoplasms*/Pituitary Neoplasms*/drug therapy ; Dopamine Agonists*/Dopamine Agonists*/Dopamine Agonists*/therapeutic use

• Source: Endocrinology and metabolism (Seoul, Korea) [Endocrinol Metab (Seoul)] 2024 Dec; Vol. 39 (6), pp. 819-826. Date of Electronic Publication: 2024 Oct 14.Publisher: Korean Endocrine Society Country of Publication: Korea (South) NLM ID: 101554139 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

Paradoxical effect of dopamine-agonists on IGF-1 in patients with prolactinoma: the role of weight.

• Authors : Caprio S; Section of Endocrinology, Department of Medical, Surgical and Neurogical Sciences, University of Siena, Siena, Italy.; Pilli T

Subjects: Prolactinoma*/Prolactinoma*/Prolactinoma*/drug therapy ; Prolactinoma*/Prolactinoma*/Prolactinoma*/blood ; Insulin-Like Growth Factor I*/Insulin-Like Growth Factor I*/Insulin-Like Growth Factor I*/metabolism

• Source: BMC endocrine disorders [BMC Endocr Disord] 2024 Jun 20; Vol. 24 (1), pp. 94. Date of Electronic Publication: 2024 Jun 20.Publisher: BioMed Central Country of Publication: England NLM ID: 101088676 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6823

تفاصيل العنوان

Ultra-rapid prolactin normalization with cabergoline in a premenopausal woman with epilepsy and giant prolactinoma.

• Authors : Pokem, Perrin Ngougni¹ (AUTHOR); Constantinescu, Stefan Matei² (AUTHOR); Cools, Hadrien¹ (AUTHOR)

• Source: JCEM Case Reports. May2026, Vol. 4 Issue 5, p1-5. 5p.

تفاصيل العنوان

A new and useful tool for differentiating prolactinomas from non-functioning pituitary adenomas: a pilot study of the cabergoline disconnection test.

• Authors : Galliano SA; Endocrinology and Metabolism Discipline, Neuroendocrinology Unit, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.; Stumpf MAM

Subjects: Prolactinoma*/Prolactinoma*/Prolactinoma*/diagnosis ; Prolactinoma*/Prolactinoma*/Prolactinoma*/blood ; Prolactinoma*/Prolactinoma*/Prolactinoma*/drug therapy

• Source: Einstein (Sao Paulo, Brazil) [Einstein (Sao Paulo)] 2025 Sep 15; Vol. 23, pp. eAO1694. Date of Electronic Publication: 2025 Sep 15 (Print Publication: 2025).Publisher: Instituto de Ensino e Pesquisa Albert Einstein Country of Publication: Brazil NLM ID: 101281800 Publication Model: eCollection Cited Medium:

تفاصيل العنوان

Prolactinoma in males: a single center experience in Northern Africa.

• Authors : El Yamani, Nada¹; Jamal, Anouar¹; Bouichrat, Nissrine^1,2

• Source: Medicine & Pharmacy Reports: Clujul Medical. 2026, Vol. 99 Issue 1, p23-29. 7p.

تفاصيل العنوان

Dopamine Agonist Therapy Induced Fatal Pneumocephalus in Giant Prolactinoma.

• Authors : H., Archana M.¹ (AUTHOR); Lila, Anurag Ranjan¹ (AUTHOR); Karlekar, Manjiri¹ (AUTHOR)

• Source: JCEM Case Reports. Feb2026, Vol. 4 Issue 2, p1-4. 4p.

تفاصيل العنوان

The effect of hyperprolactinemia and its treatment on oxidative stress.

• Authors : Keti DB; Department of Biochemistry, Erciyes University Medical School, Kayseri, Turkey.; Mammadov M

Subjects: Hyperprolactinemia*/Hyperprolactinemia*/Hyperprolactinemia*/drug therapy ; Hyperprolactinemia*/Hyperprolactinemia*/Hyperprolactinemia*/etiology ; Hyperprolactinemia*/Hyperprolactinemia*/Hyperprolactinemia*/blood

• Source: Endocrine research [Endocr Res] 2025 Aug; Vol. 50 (3), pp. 184-189. Date of Electronic Publication: 2025 May 27.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8408548 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان